Lyell Immunopharma
Price & Volume
Stats
See more52W Range | $7.65-$30 |
Market Cap | $362.5M |
Shares Short | 233,067 |
Financials
See moreRevenue (12 Mos) | $60,000 |
Revenue Growth (YoY) | -38.5% |
Gross Profit (12 Mos) | $60,000 |
Diluted EPS | -$24.26 |
News
See moreYahoo Finance • 2 months ago
Lyell Immunopharma CEO Seely sells shares worth $8k
Yahoo Finance • 2 months ago
Lyell Immunopharma Inc (NASDAQ:LYEL) Reports Q2 2025 Earnings Beat with Clinical Progress on LYL314
Yahoo Finance • 2 months ago
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2025
Yahoo Finance • 3 months ago
Lyell Immunopharma registers 625,000 shares for resale
About
CEO | Dr. Lynn Seely M.D., Ph.D. |
Address | 201 Haskins Way, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 300 |
